| D'lisa Renee Haas, PHARMD | |
|
5500 Highway 5 N, Bryant, AR 72022-7000 | |
| (501) 847-7420 | |
| Not Available |
| Full Name | D'lisa Renee Haas |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5500 Highway 5 N, Bryant, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164706032 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 9299 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| D'lisa Renee Haas, PHARMD 224 Country Club Parkway, Maumelle, AR 72113 Ph: (501) 350-5342 | D'lisa Renee Haas, PHARMD 5500 Highway 5 N, Bryant, AR 72022-7000 Ph: (501) 847-7420 |
News Archive
Results from a latest large-scale clinical trial called Azure found that Novartis AG's bone drug Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA .
A novel, orally administered drug candidate, TTP488, has demonstrated clinical evidence of slowing of cognitive decline over 18 months of therapy in patients with mild to moderate Alzheimer's disease.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces the launch in the United States of Oravig® (known as Loramyc® in Europe) for the treatment of oropharyngeal candidiasis (OPC) in adults by its commercial partner, Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc..
› Verified 6 days ago
Me-kyoung Choi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3220 N Reynolds Rd, Bryant, AR 72022 Phone: 501-847-0803 | |
Sheree Mcconkey, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 Monticello W, Bryant, AR 72022 Phone: 501-847-6620 | |
Keri Stuff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5500 Highway 5 N, Bryant, AR 72022 Phone: 501-847-7420 | |
Jeffrey Reagan Limbaugh Snow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Highway 5 N, Bryant, AR 72022 Phone: 501-847-2880 | |
Jamie Bourland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7377 Alcoa Rd, Bryant, AR 72022 Phone: 501-620-0334 | |
Benjamin Ramsey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2203 N Reynolds Rd, Bryant, AR 72022 Phone: 501-481-8964 |